Achieve Life Sciences, Inc.ACHV
Price (close)
$7.54
Market cap
$775.9M
P/E
—
Revenue (TTM)
—
Net income
-$114.0M
Dividend yield
—
1-year total return
153.9%
Net margin
—
Revenue growth
—
Debt / equity
—
What Achieve Life Sciences, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net income | -$14.7M | -$33.2M | -$42.4M | -$29.8M | -$39.8M | -$54.6M |
| Free cash flow | -$13.5M | — | — | -$24.5M | — | -$49.5M |
More on ACHV.
- Achieve Life Sciences, Inc. summary
- Achieve Life Sciences, Inc. financial statements
- Achieve Life Sciences, Inc. key metrics
- Achieve Life Sciences, Inc. health scores and style box
- Achieve Life Sciences, Inc. earnings
- Achieve Life Sciences, Inc. dividends
- Achieve Life Sciences, Inc. valuation
- Achieve Life Sciences, Inc. ownership and insiders
- Achieve Life Sciences, Inc. peers
Figures from Achieve Life Sciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.